Page 35 - 2022-23-中国全科医学

·2848· http://www.chinagp.net E-mail:zgqkyx@chinagp.net.cn

review and meta-regression analysis［J］. Atherosclerosis，2018， artery stenosis［J］. Vessel Plus，2019. DOI：10.20517/2574-
276：67-73. DOI：10.1016/j.atherosclerosis.2018.07.020. 1209.2018.69.
［7］COPPOLA T，BERAUD-DUFOUR S，LEBRUN P，et al. Bridging ［19］CEGLA J，FRANCE M，MARCOVINA S M，et al. Lp（a）：
the gap between diabetes and stroke in search of high clinical when and how to measure it［J］. Ann Clin Biochem，2021，
relevance therapeutic targets［J］. Neuromolecular Med，2019， 58（1）：16-21. DOI：10.1177/0004563220968473.
21（4）：432-444. DOI：10.1007/s12017-019-08563-5. ［20］WU M F，XU K Z，GUO Y G，et al. Lipoprotein（a） and
［8］NAYLOR A R，RICCO J B，DE BORST G J，et al. Editor's choice atherosclerotic cardiovascular disease：current understanding and
- management of atherosclerotic carotid and vertebral artery disease： future perspectives［J］. Cardiovasc Drugs Ther，2019，33（6）：
2017 clinical practice guidelines of the European society for vascular 739-748. DOI：10.1007/s10557-019-06906-9.
surgery （ESVS）［J］. Eur J Vasc Endovasc Surg，2018，55（1）： ［21］O'DONOGHUE M L，FAZIO S，GIUGLIANO R P，et al.
3-81. DOI：10.1016/j.ejvs.2017.06.021. Lipoprotein（a），PCSK9 inhibition，and cardiovascular
［9］SAFRI L S，LIP H T C，SARIPAN M I，et al. Older age and risk［J］. Circulation，2019，139（12）：1483-1492. DOI：
duration of exposure to type 2 diabetes in selective screening of 10.1161/CIRCULATIONAHA.118.037184.
asymptomatic carotid artery stenosis for primary stroke prevention-a ［22］HIPPE D S，PHAN B A P，SUN J，et al. Lp（a） （lipoprotein（a））
single institution experience［J］. Prim Care Diabetes，2020，14（4）： levels predict progression of carotid atherosclerosis in subjects with
364-369. DOI：10.1016/j.pcd.2019.10.001. atherosclerotic cardiovascular disease on intensive lipid therapy：
［10］SULTANA N，ISLAM M R. Doppler evaluation of carotid vessels in an analysis of the AIM-HIGH （atherothrombosis intervention
type 2 diabetes［J］. Mymensingh Med J，2020，29（3）：572- in metabolic syndrome with low HDL/high triglycerides：impact
578. on global health outcomes） carotid magnetic resonance imaging
［11］PEARCE I，SIMÓ R，LÖVESTAM-ADRIAN M，et al. Association substudy-brief report［J］. Arterioscler Thromb Vasc Biol，2018，
between diabetic eye disease and other complications of diabetes： 38（3）：673-678. DOI：10.1161/ATVBAHA.117.310368.
implications for care. A systematic review［J］. Diabetes Obes ［23］VAN DAM-NOLEN D H K，VAN DIJK A C，CROMBAG G A
Metab，2019，21（3）：467-478. DOI：10.1111/dom.13550. J C，et al. Lipoprotein（a） levels and atherosclerotic plaque
［12］SIMÓ R，BAÑERAS J，HERNÁNDEZ C，et al. Diabetic characteristics in the carotid artery：the Plaque at RISK （PARISK）
retinopathy as an independent predictor of subclinical cardiovascular study［J］. Atherosclerosis，2021，329：22-29. DOI：10.1016/j.
disease：baseline results of the PRECISED study［J］. BMJ atherosclerosis.2021.06.004.
Open Diabetes Res Care，2019，7（1）：e000845. DOI： ［24］BOS S，DUVEKOT M H C，TOUW-BLOMMESTEIJN A C，et al.
10.1136/bmjdrc-2019-000845. Lipoprotein （a） levels are not associated with carotid plaques and
［13］GAO L，ZHAO W，YANG J K，et al. Proliferative diabetic carotid intima media thickness in statin-treated patients with familial
retinopathy in patients with type 2 diabetes correlates with the hypercholesterolemia［J］. Atherosclerosis，2015，242（1）：
presence of atherosclerosis cardiovascular disease［J］. Diabetol 226-229. DOI：10.1016/j.atherosclerosis.2015.07.024.
Metab Syndr，2021，13（1）：48. DOI：10.1186/s13098-021- ［25］SUN D，ZHOU B Y，ZHAO X，et al. Lipoprotein（a） level
00666-z. associates with coronary artery disease rather than carotid lesions in
［14］SC HE NONE A L，C OHE N A，SHISHE HB OR M H. patients with familial hypercholesterolemia［J］. J Clin Lab Anal，
Asymptomatic carotid artery disease：a personalized approach to 2018，32（7）：e22442. DOI：10.1002/jcla.22442.
management［J］. Cleve Clin J Med，2015，82（12）：855- ［26］FRANK R N. Diabetic retinopathy and systemic factors［J］.
863. DOI：10.3949/ccjm.82a.14144. Middle East Afr J Ophthalmol，2015，22（2）：151-156. DOI：
［15］VOUILLARMET J，HELFRE M，MAUCORT-BOULCH D，et al. 10.4103/0974-9233.154388.
Carotid atherosclerosis progression and cerebrovascular events in ［27］BEK T. Systemic risk factors contribute differently to the development
patients with diabetes［J］. J Diabetes Complications，2016，30（4）： of proliferative diabetic retinopathy and clinically significant macular
638-643. DOI：10.1016/j.jdiacomp.2016.01.022. oedema［J］. Diabetologia，2020，63（11）：2462-2470.
［16］DRINKWATER J J，DAVIS T M E，HELLBUSCH V，et al. DOI：10.1007/s00125-020-05234-0.
Retinopathy predicts stroke but not myocardial infarction in type 2 ［28］WAT N，WONG R L，WONG I Y. Associations between diabetic
diabetes：the Fremantle Diabetes Study Phase Ⅱ［J］. Cardiovasc retinopathy and systemic risk factors［J］. Hong Kong Med J，
Diabetol，2020，19（1）：43. DOI：10.1186/s12933-020- 2016，22（6）：589-599. DOI：10.12809/hkmj164869.
01018-3. ［29］MÁRQUEZ D F，RUIZ-HURTADO G，SEGURA J，et al.
［17］XIAO Y Y，YUAN M K，XI P，et al. Relationship between Microalbuminuria and cardiorenal risk：old and new evidence
carotid plaque and diabetic retinopathy in type 2 diabetes mellitus in different populations［J］. F1000 Research，2019，8：
patients［J］. Zhonghua Yi Xue Za Zhi，2017，97（24）：1871- F1000FacultyRev-1659. DOI：10.12688/f1000research.17212.1.
1874. DOI：10.3760/cma.j.issn.0376-2491.2017.24.006. （收稿日期：2022-02-10；修回日期：2022-04-26）
［18］MIURA Y，SUZUKI H. Dyslipidemia and atherosclerotic carotid （本文编辑：贾萌萌）